imodium original
limedika, uab - loperamido hidrochloridas - kietosios kapsulės - 2 mg - loperamide
zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - kiti virškinimo trakto ir metabolizmo produktus, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
methadone g.l. pharma
g.l. pharma gmbh - metadono hidrochloridas - koncentratas geriamajam tirpalui - 10 mg/ml - methadone
minirin
ferring gmbh - desmopresino acetatas - nosies purškalas (tirpalas) - 240 µg; 120 µg; 10 µg/išpurškime; 0,2 mg; 0,1 mg; 60 µg - desmopressin
levomethadone g.l. pharma
g.l. pharma gmbh - levometadono hidrochloridas - koncentratas geriamajam tirpalui - 5 mg/ml - levomethadone
desmopressin sumar
sumar pharma ehf - desmopresinas - poliežuvinės tabletės - 60 µg - desmopressin
desmopressin sumar
sumar pharma ehf - desmopresinas - poliežuvinės tabletės - 240 µg - desmopressin
verzenios
eli lilly nederland b.v. - abemaciclib - krūties navikai - antinavikiniai vaistai - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
onivyde pegylated liposomal (previously known as onivyde)
les laboratoires servier - irinotecan anhydrous free-base - kasos navikai - antinavikiniai vaistai - suaugusių pacientų, kuriems pasireiškė gemcitabino terapija, metastazavusios kasos adenokarcinomos gydymas kartu su 5 fluorouracilu (5 fu) ir leukovorinu (lv).
ofev
boehringer ingelheim international gmbh - nintedanibas - idiopatinis plaučių fibrozė - antinavikiniai vaistai - ofve skirtas suaugusiems skirtiems idiopatiniam plaučių fibrozės (ipf) gydymui..